S
SUPN
Supernus Pharma
46.64
-1.13-2.37%After Hours: 46.64 0.00 0.00%17:06 05/27 EDT
OPEN/PREV CLOSE47.76/47.77
TODAY RANGE46.40-48.38
VOL710.99K
MARKET CAP2.71B
52 WEEK RANGE30.83-59.68
AVG VOL (3M)642.46K
% TURNOVER1.23%
TURNOVER--
P/E (TTM)-91.1115
% RANGE4.13%
EPS(TTM)-0.5119
P/E(FORWARD)113.76
P/B2.514
BVPS18.55
DIVIDEND--
P/S3.727
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.59B
SHARES OUTSTANDING58.04M
NEXT EARNINGS08/03-08/07
FREE FLOAT55.45M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/20 22:24
Supernus Reaches Milestone, Triggers Contingent Value Rights Payment
NASDAQ·05/12 17:10
What to Know About This Fund’s Sale of a Pharma Stock Up 56% in a Year
TipRanks·05/06 15:36
Stifel Nicolaus Reaffirms Their Hold Rating on Supernus Pharmaceuticals (SUPN)
TipRanks·05/06 11:59
Piper Sandler Reaffirms Their Buy Rating on Supernus Pharmaceuticals (SUPN)
TipRanks·05/06 04:05
SUPN: Buy Rating Reiterated as Strong Growth Supports Unchanged $65 Price Target
Seeking Alpha·05/06 02:22
Supernus outlines $840M-$870M 2026 revenue outlook as ONAPGO second-supplier filing targeted for Q3
TipRanks·05/06 01:00
Supernus Pharmaceuticals Earnings Call Signals Growth Momentum
Reuters·05/05 20:53
Supernus reiterates full-year 2026 financial guidance
Seeking Alpha·05/05 20:49
Supernus Pharmaceuticals GAAP EPS of -$0.04 misses by $0.03, revenue of $207.7M beats by $14.78M
Same Industry
Name/Symbol
Change%
Price